Carl Zeiss Meditec AG Statistics
Total Valuation
Carl Zeiss Meditec AG has a market cap or net worth of 4.51 billion. The enterprise value is 5.08 billion.
Market Cap | 4.51B |
Enterprise Value | 5.08B |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
Earnings Date | Feb 12, 2025 |
Ex-Dividend Date | Mar 22, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.66% |
Shares Change (QoQ) | -2.80% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 34.63M |
Valuation Ratios
The trailing PE ratio is 22.64.
PE Ratio | 22.64 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.36 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.65, with an EV/FCF ratio of 28.40.
EV / Earnings | 25.51 |
EV / Sales | 2.36 |
EV / EBITDA | 19.65 |
EV / EBIT | 26.47 |
EV / FCF | 28.40 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.27.
Current Ratio | 2.13 |
Quick Ratio | 1.06 |
Debt / Equity | 0.27 |
Debt / EBITDA | 2.20 |
Debt / FCF | 3.45 |
Interest Coverage | 6.37 |
Financial Efficiency
Return on equity (ROE) is 8.52% and return on invested capital (ROIC) is 4.74%.
Return on Equity (ROE) | 8.52% |
Return on Assets (ROA) | 3.65% |
Return on Capital (ROIC) | 4.74% |
Revenue Per Employee | 402,164 |
Profits Per Employee | 34,788 |
Employee Count | 5,730 |
Asset Turnover | 0.64 |
Inventory Turnover | 1.85 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.92% in the last 52 weeks. The beta is 1.04, so Carl Zeiss Meditec AG's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | -52.92% |
50-Day Moving Average | 54.65 |
200-Day Moving Average | 73.67 |
Relative Strength Index (RSI) | 53.74 |
Average Volume (20 Days) | 14,306 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Carl Zeiss Meditec AG had revenue of 2.30 billion and earned 199.34 million in profits. Earnings per share was 2.24.
Revenue | 2.30B |
Gross Profit | 1.21B |
Operating Income | 209.02M |
Pretax Income | 268.64M |
Net Income | 199.34M |
EBITDA | 251.00M |
EBIT | 209.02M |
Earnings Per Share (EPS) | 2.24 |
Balance Sheet
The company has 22.62 million in cash and 617.70 million in debt, giving a net cash position of -595.07 million.
Cash & Cash Equivalents | 22.62M |
Total Debt | 617.70M |
Net Cash | -595.07M |
Net Cash Per Share | n/a |
Equity (Book Value) | 2.29B |
Book Value Per Share | 26.01 |
Working Capital | 717.88M |
Cash Flow
In the last 12 months, operating cash flow was 275.84 million and capital expenditures -96.83 million, giving a free cash flow of 179.02 million.
Operating Cash Flow | 275.84M |
Capital Expenditures | -96.83M |
Free Cash Flow | 179.02M |
FCF Per Share | n/a |
Margins
Gross margin is 52.69%, with operating and profit margins of 9.07% and 8.65%.
Gross Margin | 52.69% |
Operating Margin | 9.07% |
Pretax Margin | 11.66% |
Profit Margin | 8.65% |
EBITDA Margin | 10.89% |
EBIT Margin | 9.07% |
FCF Margin | 7.77% |
Dividends & Yields
This stock pays an annual dividend of 0.82, which amounts to a dividend yield of 1.66%.
Dividend Per Share | 0.82 |
Dividend Yield | 1.66% |
Dividend Growth (YoY) | -0.62% |
Years of Dividend Growth | n/a |
Payout Ratio | 54.95% |
Buyback Yield | 0.66% |
Shareholder Yield | 2.32% |
Earnings Yield | 4.42% |
FCF Yield | 3.97% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Carl Zeiss Meditec AG has an Altman Z-Score of 5.11.
Altman Z-Score | 5.11 |
Piotroski F-Score | n/a |